This edition of RxInformer continues to monitor evolving trends in workers’ comp, from the increasing utilization of GLP-1 drugs, to drug shortages and their impact on claims, and how early pharmacy activity can signal claim risks.
Drug shortages are no longer just a pharmacy issue but a growing claims management risk in workers’ compensation, contributing to more complex claims, delayed care, and higher costs.
These diseases are infrequent in workers' comp, but they can incur significant costs as these diseases are often present for life, requiring ongoing monitoring, treatment, and medication.
High-impact drugs, including topicals and compounds, represent proportionately low utilization compared to opioids or NSAIDs, but they can increase pharmacy spend exponentially on impacted claims.
Explore the growing interest in research around psychedelic substances for medical applications related to workers' comp populations, including but not limited to: psilocybin, ketamine, MDMA
Receive twice annual email alerts when new issues are published!
RxInformer
Since 2010, the semi-annual RxInformer clinical journal has been a trusted source of timely information and guidance for workers’ comp payers on how best to manage the care of injured worker claimants and plan for the challenges that lay ahead. The publication is an important part of Healthesystems’ proactive approach to advocating for quality care of injured workers while managing the costs associated with treatment.
